Lupin resolves manufacturing issues raised by USFDA for Goa, Pithampur facilities

28 Jul 2023 Evaluate

Lupin has resolved manufacturing issues raised by the US health regulator regarding its Goa and Pithampur-based manufacturing facilities. The company has received a correspondence from the US Food and Drug Administration (USFDA) that it (Lupin) has now addressed the concerns raised in the warning letter for its facilities in Goa and Pithampur Unit-2. This comes after the satisfactory evaluation of the corrective actions taken by the company in response to the Warning Letter issued by the USFDA on November 6, 2017.

Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.

Lupin Share Price

2140.30 -24.75 (-1.14%)
23-Jan-2026 13:51 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1635.10
Dr. Reddys Lab 1237.05
Cipla 1306.10
Zydus Lifesciences 883.00
Lupin 2140.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×